Stock QTXB QUANTRX BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials QuantRx Biomedical Corporation

Equities

QTXB

US74765N1090

Advanced Medical Equipment & Technology

Market Closed - OTC Markets
Other stock markets
 01:37:42 2024-02-26 pm EST 		5-day change 1st Jan Change
0.004 USD -.--% Intraday chart for QuantRx Biomedical Corporation -.--% -49.37%
2022 QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
2022 Michael Abrams Resigns as a Member of the Board of Directors of QuantRx Biomedical Corporation CI

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 0.543 0.4879 0.181 0.2912 0.4722 0.787
Enterprise Value (EV) 1 2.236 1.974 1.865 1.699 1.971 2.35
P/E ratio -1.29 x 0.62 x -0.23 x -0.47 x -1.87 x -3.03 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -17 x -12.8 x -8.29 x - - -
EV / FCF -19.8 x -13.1 x 9.91 x -29.8 x -182 x 71.7 x
FCF Yield -5.06% -7.65% 10.1% -3.35% -0.55% 1.4%
Price to Book -0.29 x -0.53 x -0.12 x -0.13 x -0.19 x -0.29 x
Nbr of stocks (in thousands) 78,696 78,696 78,696 78,696 78,696 78,696
Reference price 2 0.006900 0.006200 0.002300 0.003700 0.006000 0.0100
Announcement Date 4/17/17 4/17/18 4/16/19 4/14/20 4/15/21 4/15/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales - - - - - -
EBITDA 1 -0.1317 -0.1543 -0.225 - - -
EBIT 1 -0.1388 -0.1652 -0.2359 -0.2017 -0.0606 -0.0434
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.398 0.8691 -0.7368 -0.6219 -0.2527 -0.26
Net income 1 -0.398 0.8691 -0.7368 -0.6219 -0.2527 -0.26
Net margin - - - - - -
EPS 2 -0.005360 0.009999 -0.0100 -0.007902 -0.003211 -0.003304
Free Cash Flow 1 -0.1131 -0.1509 0.1882 -0.0569 -0.0108 0.0328
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/17/17 4/17/18 4/16/19 4/14/20 4/15/21 4/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 1.69 1.49 1.68 1.41 1.5 1.56
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -12.86 x -9.627 x -7.485 x - - -
Free Cash Flow 1 -0.11 -0.15 0.19 -0.06 -0.01 0.03
ROE (net income / shareholders' equity) 25.6% -71.6% 65.3% 34.2% 11.2% 10.4%
ROA (Net income/ Total Assets) -30.4% -12.9% -14.9% -35.1% -39.3% -88.4%
Assets 1 1.31 -6.75 4.93 1.774 0.6429 0.2943
Book Value Per Share 2 -0.0200 -0.0100 -0.0200 -0.0300 -0.0300 -0.0300
Cash Flow per Share 2 0 0.0100 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 4/17/17 4/17/18 4/16/19 4/14/20 4/15/21 4/15/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
QUANTRX BIOMEDICAL CORPORATION Stock QuantRx Biomedical Corporation
-49.37% 315K
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.69% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.69% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+10.90% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+25.41% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.27% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+12.72% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.40% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+15.03% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. QTXB Stock
  4. Financials QuantRx Biomedical Corporation